V

Voyager Therapeutics
D

VYGR

3.64000
USD
0.10
(2.82%)
مغلق
حجم التداول
5,607
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
201,340,823
أصول ذات صلة
ALNY
ALNY
3.98
(1.56%)
259.33 USD
BMRN
BMRN
-0.700
(-1.12%)
61.980 USD
C
CRSP
0.520
(1.38%)
38.220 USD
E
EDIT
0.01500
(0.93%)
1.63000 USD
I
IONS
1.100
(3.47%)
32.780 USD
N
NTLA
0.20000
(2.32%)
8.83000 USD
REGN
REGN
15.98
(2.71%)
606.12 USD
S
SGMO
-0.01210
(-1.63%)
0.72800 USD
المزيد
الأخبار المقالات

العنوان: Voyager Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.